There’s No Need To Panic Or Freeze When It Comes To Replimune Group Inc (NASDAQ: REPL)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Replimune Group Inc is $932.65M. A total of 0.68 million shares were traded on the day, compared to an average of 737.20K shares.

In the most recent transaction, Patel Sushil sold 10,000 shares of REPL for 12.42 per share on Dec 16 ’24. After the transaction, the Chief Executive Officer now owns 202,014 company shares. In a previous transaction on Dec 16 ’24, Sushil Patel bought 15,000 shares at 12.57 per share.

Among the insiders who sold shares, Xynos Konstantinos disposed of 7,246 shares on Nov 18 ’24 at a per-share price of $10.78. This resulted in the Chief Medical Officer holding 109,885 shares of REPL after the transaction. In another insider transaction, Sarchi Christopher sold 5,207 shares at $10.78 per share on Nov 18 ’24. Company shares held by the Chief Commercial Officer now total 87,045.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, REPL has a high of $17.00 and a low of $4.92.

As of this writing, REPL has an earnings estimate of -$0.69 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of -$0.64 per share and a lower estimate of -$0.74.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. REPL’s latest balance sheet shows that the firm has $395.65M in Cash & Short Term Investments as of fiscal 2022. There were $32.84M in debt and $20.76M in liabilities at the time. Its Book Value Per Share was $6.26, while its Total Shareholder’s Equity was $411.23M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for REPL is Buy with a score of 5.00.

Most Popular

Related Posts